During the past decade, Institut Universitaire en Santé Mentale de Montréal conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Universitaire en Santé Mentale de Montréal" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal" with 2 trials sponsored, "Ciusss de L'Est de l'Île de Montréal" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "diaMentis Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Universitaire en Santé Mentale de Montréal" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal" with 1 trials as a collaborator and "Otsuka Canada Pharmaceutical Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institut Universitaire en Santé Mentale de Montréal" are "Schizophrenia" (4 trials), "Auditory Hallucination, Verbal" (2 trials), "Treatment-resistant Schizophrenia" (2 trials), "Bipolar I Disorder" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Institut Universitaire en Santé Mentale de Montréal" in a lesser frequency.

Most popular intervention types in "Institut Universitaire en Santé Mentale de Montréal" are "Behavioral" (4 trials), "Drug" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Avatar Therapy" (1 trials), "Avatar therapy" (1 trials), "BI 409306" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Universitaire en Santé Mentale de Montréal" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Institut Universitaire en Santé Mentale de Montréal". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Institut Universitaire en Santé Mentale de Montréal, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Universitaire en Santé Mentale de Montréal, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".